SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Xtant Medical Holdings, (XTNT) — Jul 6, 2016

Xtant Medical Holdings, Inc.
Date: July 6, 2016 · CIK: 0001453593 · Accession: 0001144204-16-111652

AI Filing Summary & Sentiment

File numbers found in text: 333-203492

Date
July 6, 2016
Author
Not clearly detected
Form
CORRESP
Company
Xtant Medical Holdings, Inc.

Letter

July 6, 2016

VIA EDGAR AND FACSIMILE

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Suzanne Hayes

Tara Keating Brooks

Re: Xtant Medical Holdings, Inc. (the “Company”)

Post-Effective Amendment No. 2 to Registration Statement on Form S-1

File No. 333-203492

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 9:00 AM on July 7, 2016, or as soon thereafter as is practicable.

The Company hereby acknowledges that:

· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

· the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very truly yours,
XTANT MEDICAL HOLDINGS, INC.

Show Raw Text
CORRESP
1
filename1.htm

July 6, 2016

VIA EDGAR AND FACSIMILE

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

 Attention: Suzanne Hayes

Tara Keating Brooks

 Re: Xtant Medical Holdings, Inc. (the “Company”)

Post-Effective Amendment No. 2 to Registration Statement on Form S-1

File No. 333-203492

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred
to above be accelerated so that it will be declared effective at 9:00 AM on July 7, 2016, or as soon thereafter as is practicable.

The Company hereby acknowledges that:

 · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
the Commission from taking any action with respect to the filing;

 · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 · the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

Very truly yours,

XTANT MEDICAL HOLDINGS, INC.

/s/ John Gandolfo

John Gandolfo

Chief Financial Officer

 cc: Travis Leach, Ballard Spahr LLP